327 related articles for article (PubMed ID: 31788448)
1. Comparative Approach to the Temporo-Spatial Organization of the Tumor Microenvironment.
Langsten KL; Kim JH; Sarver AL; Dewhirst M; Modiano JF
Front Oncol; 2019; 9():1185. PubMed ID: 31788448
[TBL] [Abstract][Full Text] [Related]
2. 3D Microfluidic Bone Tumor Microenvironment Comprised of Hydroxyapatite/Fibrin Composite.
Ahn J; Lim J; Jusoh N; Lee J; Park TE; Kim Y; Kim J; Jeon NL
Front Bioeng Biotechnol; 2019; 7():168. PubMed ID: 31380359
[TBL] [Abstract][Full Text] [Related]
3. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
[TBL] [Abstract][Full Text] [Related]
5. The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.
Ilie MD; Vasiljevic A; Raverot G; Bertolino P
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31640258
[TBL] [Abstract][Full Text] [Related]
6. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
Yang S; Gao H
Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
[TBL] [Abstract][Full Text] [Related]
8. Complex interplay between tumor microenvironment and cancer therapy.
Shen M; Kang Y
Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
[TBL] [Abstract][Full Text] [Related]
9. The cyan fluorescent protein nude mouse as a host for multicolor-coded imaging models of primary and metastatic tumor microenvironments.
Suetsugu A; Hassanein MK; Reynoso J; Osawa Y; Nagaki M; Moriwaki H; Saji S; Bouvet M; Hoffman RM
Anticancer Res; 2012 Jan; 32(1):31-8. PubMed ID: 22213285
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids.
Devarasetty M; Forsythe SD; Shelkey E; Soker S
Tissue Eng Regen Med; 2020 Dec; 17(6):759-771. PubMed ID: 32399776
[TBL] [Abstract][Full Text] [Related]
11. Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs.
Osman A; Afify SM; Hassan G; Fu X; Seno A; Seno M
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260363
[TBL] [Abstract][Full Text] [Related]
12. Mouse Models to Evaluate the Functional Role of the Tumor Microenvironment in Cancer Progression and Therapy Responses.
McAndrews KM; Mahadevan KK; Kalluri R
Cold Spring Harb Perspect Med; 2024 Jan; ():. PubMed ID: 38191175
[TBL] [Abstract][Full Text] [Related]
13. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
Wu Q; Zhou L; Lv D; Zhu X; Tang H
J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
[TBL] [Abstract][Full Text] [Related]
14. Targeting Tumor Microenvironment for Cancer Therapy.
Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.
Wang S; Li Y; Xing C; Ding C; Zhang H; Chen L; You L; Dai M; Zhao Y
Am J Cancer Res; 2020; 10(7):1937-1953. PubMed ID: 32774994
[TBL] [Abstract][Full Text] [Related]
16. Targeting the microenvironment in solid tumors.
Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
[TBL] [Abstract][Full Text] [Related]
17. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
[TBL] [Abstract][Full Text] [Related]
18. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
Pietilä M; Ivaska J; Mani SA
Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
[TBL] [Abstract][Full Text] [Related]
19. Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.
Pachynski RK; Wang P; Salazar N; Zheng Y; Nease L; Rosalez J; Leong WI; Virdi G; Rennier K; Shin WJ; Nguyen V; Butcher EC; Zabel BA
Front Immunol; 2019; 10():983. PubMed ID: 31139180
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.
Gupta S; Roy A; Dwarakanath BS
Front Oncol; 2017; 7():68. PubMed ID: 28447025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
